Acadia Pharmaceuticals (ACAD) Asset Utilization Ratio (2011 - 2026)

Acadia Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.69 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 19.53% year-over-year to 0.69; the TTM figure through Mar 2026 stood at 0.69 (down 19.53% YoY), while the FY2025 annual figure was 0.78, down 21.27% from the prior year.
• Asset Utilization Ratio was 0.69 for Q1 2026 at Acadia Pharmaceuticals, down from 0.74 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.05 in Q4 2023 to a low of 0.69 in Q1 2026.
• Historically, Asset Utilization Ratio has averaged 0.88 across 5 years, with a median of 0.86 in 2025.
• The sharpest annual moves came in 2022 and 2026: Asset Utilization Ratio soared 32.27% in 2022, then dropped 19.53% in 2026.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.87 in 2022, then grew by 21.01% to 1.05 in 2023, then retreated by 15.85% to 0.88 in 2024, then slipped by 16.35% to 0.74 in 2025, then retreated by 6.64% to 0.69 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.69 (Q1 2026), 0.74 (Q4 2025), and 0.82 (Q3 2025), per Business Quant data.